Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of subsequent cardiovascular events in women, but not in men, according to research presented at The Liver Meeting held by the American Association for the Study of Liver Diseases.

October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare ...

Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to commence a confirmatory clinical study evaluating the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System (EVAS) for the endovascular treatment of infrarenal abdominal aortic aneurysms. The EVAS2 IDE Multicenter Safety and Effectiveness Confirmatory Study (EVAS2) will prospectively evaluate the refined Indications for Use (IFU) and the Nellix Gen2 EVAS System.

October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the Xarelto vascular dose plus aspirin 100 ...

The American College of Cardiology and the American Heart Association recently released updated clinical performance and quality measures to benchmark and improve the quality of care for adult patients hospitalized with ST-elevation and non–ST-elevation myocardial infarction (STEMI and NSTEMI, respectively).

The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use criteria addressing the evaluation and use of multimodality imaging in the diagnosis and management of valvular heart disease.